Aeglea Biotherapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.9M | 89k | 32.76 |
| 2025-03-31 | $2.3M | 140k | 16.14 |
| 2024-12-31 | $25M | 1.1M | 23.28 |
| 2024-09-30 | $21M | 710k | 29.41 |
| 2024-06-30 | $17M | 712k | 23.51 |
| 2024-03-31 | $27M | 708k | 37.93 |
| 2023-12-31 | $12M | 577k | 21.52 |
| 2023-09-30 | $1.2M | 97k | 12.25 |